Literature DB >> 25315744

The intestinal microbiota and microenvironment in liver.

Hong-Di Ma1, Yin-Hu Wang2, Christopher Chang3, M Eric Gershwin4, Zhe-Xiong Lian5.   

Abstract

The intestinal microbiome plays a significant role in the development of autoimmune diseases, in particular, inflammatory bowel diseases. But the interplay between the intestinal tract and the liver may explain the increased association with autoimmune liver diseases and inflammatory bowel diseases. The gut-liver axis involves multiple inflammatory cell types and cytokines, chemokines and other molecules which lead to the destruction of normal liver architecture. Triggers for the initiation of these events are unclear, but appear to include multiple environmental factors, including pathogenic or even commensal microbial agents. The variation in the gut microbiome has been cited as a major factor in the pathogenesis of autoimmune liver disease and even other autoimmune diseases. The unique positioning of the liver at the juncture of the peripheral circulation and the portal circulation augments the interaction between naïve T cells and other hepatic cells and leads to the disruption in the development of tolerance to commensal bacteria and other environmental agents. Finally, the innate immune system and in particular toll-like receptors play a significant role in the pathogenesis of autoimmune liver disease.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gut–liver axis; Inflammatory bowel disease; Intestinal microbiota; Mucosal immunity; Primary biliary cirrhosis; Primary sclerosing cholangitis

Mesh:

Year:  2014        PMID: 25315744     DOI: 10.1016/j.autrev.2014.10.013

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  17 in total

Review 1.  Gut microbiota modulate the immune effect against hepatitis B virus infection.

Authors:  D Xu; Y Huang; J Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-14       Impact factor: 3.267

Review 2.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

Review 3.  Xenobiotics and loss of tolerance in primary biliary cholangitis.

Authors:  Jinjun Wang; Guoxiang Yang; Alana Mari Dubrovsky; Jinjung Choi; Patrick S C Leung
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

Review 5.  On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota.

Authors:  Elena Gianchecchi; Alessandra Fierabracci
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 6.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

7.  Gut microbiota translocation promotes autoimmune cholangitis.

Authors:  Hong-Di Ma; Zhi-Bin Zhao; Wen-Tao Ma; Qing-Zhi Liu; Cai-Yue Gao; Liang Li; Jinjun Wang; Koichi Tsuneyama; Bin Liu; Weici Zhang; Yongjian Zhou; M Eric Gershwin; Zhe-Xiong Lian
Journal:  J Autoimmun       Date:  2018-10-17       Impact factor: 7.094

Review 8.  Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.

Authors:  Tao Zhang; Kewei Sun; Ya Wang; Lei Huang; Ren Lang; Wei Jiang
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 2.586

Review 9.  Role of gut microbiota in the modulation of atherosclerosis-associated immune response.

Authors:  Dmitry A Chistiakov; Yuri V Bobryshev; Emil Kozarov; Igor A Sobenin; Alexander N Orekhov
Journal:  Front Microbiol       Date:  2015-06-30       Impact factor: 5.640

10.  Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1.

Authors:  Hannah C Jeffery; Bonnie van Wilgenburg; Ayako Kurioka; Krishan Parekh; Kathryn Stirling; Sheree Roberts; Emma E Dutton; Stuart Hunter; Daniel Geh; Manjit K Braitch; Jeremy Rajanayagam; Tariq Iqbal; Thomas Pinkney; Rachel Brown; David R Withers; David H Adams; Paul Klenerman; Ye H Oo
Journal:  J Hepatol       Date:  2015-12-29       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.